Stem cell treatment due for a checkup

    Updated: 2012-01-11 09:09

    By Shan Juan (

    China Daily

    )

      Comments() Print Mail Large Medium  Small 分享按鈕 0

    BEIJING - China's top health authority will strictly regulate the cutting-edge stem cell treatment, which attracts thousands of patients from abroad each year, to ensure patient safety and the orderly development of the technology.

    A one-year overhaul highlighting self-examination among practitioners will be launched to detect and eliminate irregularities surrounding the issue, said Deng Haihua, spokesman of the Ministry of Health at a news conference on Tuesday.

    Stem cell treatment due for a checkup

    "All medical research and clinical practices of stem cell therapy without approval from the ministry and the State Food and Drug Administration will be put to an end after the overhaul," he told China Daily.

    Largely due to concerns over ethics, treatment efficacy, and a lack of relative laws and regulations, the health authority has never approved clinical use of the therapy on the mainland, Deng stressed.

    However, the demand and practice of the treatment have existed for a long time and are rapidly increasing, said Yang Jian, CEO of the Shanghai Medical Tourism Products and Promotion Platform.

    Industry analysis shows that at least 10,000 patients from other countries come to the mainland for the costly procedure each year and roughly 100 facilities are offering the service.

    Yang said some hospitals exploit regulatory loopholes to carry out the controversial therapy, which experts warn has no guarantee for safety and efficacy, he added.

    In China, stem cell therapy is mainly used to treat diabetes, spinal cord injury, cerebral palsy, brain injury and stroke.

    A nurse surnamed Qiao with the stem cell transplantation department of the General Hospital of Chinese People's Armed Police Forces told China Daily on Tuesday that they now have 80 patients, including 10 expats, undergoing stem cell treatment.

    Since 2003, Qiao's department has treated more than 4,000 patients from 15 countries.

    Asked how the overhaul would affect their business, she said because of the hospital's affiliation with the Armed Police, it would not be subject to management by the Ministry of Health.

    Many hospitals with a military background are carrying out the therapy, said Qiu Renzong, a leading bioethicist with the Chinese Academy of Social Sciences.

    To date, only adult stem cells sourced from bone marrow and umbilical cords for treating blood cancer have been proven safe and effective, he said.

    More scientific data in terms of safety and efficacy is needed before stem cell treatment can be applied to humans, according to the World Health Organization.

    Wang Qingyun contributed to this story.

    全球中文成人在线| 无码精品人妻一区二区三区中| 无码欧精品亚洲日韩一区| 亚洲激情中文字幕| AA区一区二区三无码精片| 无码人妻精品中文字幕免费东京热| 天堂√最新版中文在线| 超清无码无卡中文字幕| 亚洲精品无码精品mV在线观看| 欧美日韩国产中文精品字幕自在自线 | 天堂а√在线中文在线| 久久久久无码精品国产app| 亚洲日韩精品无码一区二区三区| 中文字幕成人精品久久不卡| 麻豆国产原创中文AV网站| 免费无码国产在线观国内自拍中文字幕| 无码国产精品一区二区免费3p | 亚洲AV综合色区无码一区爱AV| 最近最新高清免费中文字幕 | yellow中文字幕久久网| 中文字幕无码一区二区免费| 亚洲精品无码久久久| 无码 免费 国产在线观看91| 人妻无码第一区二区三区| 无码人妻品一区二区三区精99| 波多野结衣AV无码久久一区 | 亚洲AV综合色区无码一区爱AV| 久久久久亚洲AV无码专区首JN| 国产精品99久久久精品无码 | 久久精品国产亚洲AV无码麻豆| 亚洲AV日韩AV永久无码久久| 亚洲精品无码专区久久久 | 久久亚洲AV成人无码电影| 无码少妇一区二区| 亚洲AV日韩AV永久无码久久| 无码人妻精品一区二区在线视频| 无码人妻精品一区二区三18禁| 亚洲AV永久无码精品一百度影院| 亚洲av成人无码久久精品| 精品久久久久久无码专区不卡| 精品无码人妻一区二区三区 |